StreetAlpha
13F holdings · Q3 2026

Integral Health Asset Management

New York, NY · files as Integral Health Asset Management, LLC
Know the moment Integral Health Asset Management filesYou follow Integral Health Asset Management An email or push as soon as its next 13F reaches the SEC, with every stock it bought, sold and trimmed. Next 13F due by Feb 15, 2027
Filed
Holdings as of Sep 30, 2026Filed Nov 16, 2026Next filing due Feb 15, 2027CIK 1773206

Integral Health Asset Management reported 96 stocks worth $1.6B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are RVMD (8.0%), INSM (7.9%) and EWTX (6.0%). Compared with Q2 2026, the fund opened new positions in AMGN, INCY and ONC, added to EWTX, MRK and SRRK, trimmed RVMD, AXSM and VERA and sold out of ALHC, ABT and UNH.

Latest filing: what Integral Health Asset Management did in Q3 2026

vs Q2 2026
Filed 13F-HRView on SEC ↗
39 new12 added26 trimmed32 sold outBought about $422M · sold about $758M
New 39
See all 39 →
Added 12
See all 12 →
Trimmed 26
  • RVMD−$65.2M−33%
  • CAH−$44.5M−67%
  • EW−$36.7M−68%
  • DGX−$33.8M−73%
  • CVS−$25.7M−55%
See all 26 →
Sold out 32
See all 32 →

Dollar changes use the share change at the quarter end price. New and sold out show the whole position.

Reported value$1.6B−33.4% vs last quarter
Stocks held9639 new · 32 sold out
Top 5 weight30.5%spread out
Turnover73%of the portfolio changed

Portfolio at a glance

share of reported value · Q3 2026
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 8 qtrsHeld
1
RVMD
Revolution Medicines Inc
$130M8.0%1M−500K (−33%)8 of 8
2
INSM
Insmed Inc
$129M7.9%1.6MNo change8 of 8
3
EWTX
Edgewise Therapeutics Inc
$97.4M6.0%2.4M+400K (+20%)8 of 8
4
CYTK
Cytokinetics Inc
$72.5M4.5%1.6MNo change8 of 8
5
MRK
Merck & Co Inc
$65.4M4.0%450K+100K (+29%)5 of 8
6
SRRK
Scholar Rock Hldg Corp
$60.6M3.7%1.3M+505K (+67%)8 of 8
7
CNC
Centene Corp Del
$46.6M2.9%750K+450K (+150%)6 of 8
8
AXSM
Axsome Therapeutics Inc
$46.1M2.8%250K−50K (−17%)3 of 8
9
VERA
Vera Therapeutics Inc
$32.3M2.0%1.5M−250K (−14%)8 of 8
10
AMGN
Amgen Inc
$31.6M1.9%75KNew position1 of 8
🔒 86 more holdings in this filing. Create a free account or sign in to see them all.

Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.

Sold out

held in Q2 2026, gone in Q3 2026
StockValue last quarterShares sold
ALHC
Alignment Healthcare Inc
$47.6M2M
ABT
Abbott Labs
$36.3M400K
UNH
Unitedhealth Group Inc
$35.3M85K
NVO
Novo-Nordisk A S F
$28.8M600K
LNTH
Lantheus Hldgs Inc
$21.1M190K

🔒 Free account: see all 30.

Options

valued at the underlying shares
StockTypeValueSharesChange
EWTX
Edgewise Therapeutics Inc
Call$12.2M300K+300,000

Reported value

last 8 quarters
$1.1BQ4 '24
$903MQ1 '25
$1.1BQ2 '25
$1.4BQ3 '25
$2BQ4 '25
$1.9BQ1 '26
$2.4BQ2 '26
$1.6BQ3 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q3 2026

straight from the SEC
FiledFormQuarter
Nov 16, 202613F-HRQ3 2026SEC filing ↗

Other superinvestors

All hedge fund holdings →

Integral Health Asset Management 13F FAQ

What does Integral Health Asset Management own?

Integral Health Asset Management reported 96 stocks worth $1.6B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are RVMD (8.0%), INSM (7.9%) and EWTX (6.0%). The table above lists every position in the filing (the top 10 without an account).

What did Integral Health Asset Management buy and sell in Q3 2026?

Compared with Q2 2026: 39 new positions, 12 added to, 26 trimmed and 32 sold out. New positions include AMGN, INCY and ONC. It sold all of ALHC, ABT and UNH.

When will Integral Health Asset Management file its next 13F?

Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.

How much is Integral Health Asset Management's portfolio worth?

The Q3 2026 filing reports $1.6B in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.